Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Sanofi ADS SNY InDepth Look Sanofi ADS posts 46 EPS beat on pharma revenue Following the strong quarterly performance management raised its 2026 outlook Kymera Therapeutics KYMR Stock Interest Rate Modest Uptick 20260418 How National NSA responds when competition intensifies Touches Low 20260511 Vanguard Financials Index Fund ETF Shares VFH HighConviction DipBuy Candidate Amid ShortTerm Market Volatility Is VEON Ltd VEON stock aligned with valuation metrics Q4 2025 Below Expectations Why investors are rethinking Columbia STK Touches High 20260511 Mirum Pharmaceuticals MIRM Q1 2026 Results Miss Estimates EPS 108 vs 036 DarioHealth DRIO Delivers Q1 2026 Beat EPS 125 vs 151 Expected US Hotel Industry Faces Potential World Cup Disappointment as Survey Reveals NonEvent Sentiment Beyond Bitcoin 10 Cryptocurrencies Shaping the Digital Asset Landscape in 2026 Fuel Prices Surge Again Petrol and Diesel Hiked by 90 Paise in Second Increase This Week CommerceBanc CBSH Stock Steady at 5178 Support at 4919 20260519 Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project Meta Shares Slide After Quarterly Report Iran Internet Disruptions Weigh on User Metrics Loop Capital Initiates Coverage on American Express with Buy Rating Names It Top Pick Arm Holdings Surges 46 on Projected Fivefold Profit Growth Robinhood Launches AI Agents for Autonomous Trading and Spending IonQ Micron Anduril Emerge as Potential Next Targets for US Government Stakes Kalshi Traders Indicate 51Talk COE Q3 2025 Earnings Reported Loss of 074 Per Share as Stock Declines 37 Amphastar Pharmaceuticals AMPH Q1 2026 Earnings Significant EPS Miss Fails to Dampen Stock Sentiment DCOM Q1 2026 Earnings EPS Misses Estimates but Stock Edges Higher Construction Partners ROAD Q1 2026 Earnings Massive EPS Beat with 729 Surprise Educational Development Corporation Q1 2026 Earnings Reported Loss of 037 Per Share Stock Declines SWX Q1 2026 Earnings EPS Misses Estimates Stock Slips 215 Dr Reddys Labs RDY Edges Higher Testing Key Resistance Levels Ternium TX Slips 123 Navigating Support and Resistance Levels Gen Digital Contingent Value Rights GENVR Extend Gains at 156 Key Levels in Focus Uxin UXIN Surges Over 6 as Stock Tests Key Resistance Near 250 Alkermes ALKS Shows Modest Uptick Testing Middle of Key Range